Protherics PLC
Annual Information Update
London, UK; Brentwood, TN, US: 20 July 2007 - In accordance with Prospectus Rule
5.2, Protherics PLC ("Protherics" or the "Company"), the international
biopharmaceutical company focused on critical care and cancer, sets out below a
list of the information that has been published or made available to the public
during the period beginning 15 July 2006 up to and including 19 July 2007.
In accordance with Article 27.3 of the Prospectus Directive Regulation, we
confirm that the information referred to in this Annual Information Update was
up to date at the time it was published but it is acknowledged that such
disclosures may now be or may at any time become out of date due to changing
circumstances.
1. Announcements made via the Regulatory Information Service
All the announcements listed below can be obtained from the London Stock
Exchange website, www.londonstockexchange.com/marketnews or from the Company's
website www.protherics.com
Time/Date Brief Description of Announcement
12 July 2007 Dose Selection Announcement
29 Jun 2007 Total Voting Rights and Share Capital
27 Jun 2007 Documents Lodged with UK Listing Authority
18 Jun 2007 Notification of Major Interest in Shares
18 Jun 2007 Director Shareholding
12 Jun 2007 PDMR Shareholding
12 Jun 2007 Director Shareholding
5 Jun 2007 Final Results
4 Jun 2007 Notification of Major Interest in Shares
31 May 2007 Total Voting Rights and Share Capital
25 May 2007 Notice of Results
22 May 2007 Phase 2a Data announcement
22 May 2007 Product update
30 Apr 2007 Total Voting Rights and Share Capital
27 Apr 2007 Notification of Major Interest in Shares
26 Apr 2007 Board changes and trading update
10 Apr 2007 Blocklisting Return
10 Apr 2007 Blocklisting Return
10 Apr 2007 Blocklisting Return
10 Apr 2007 Blocklisting Return
30 Mar 2007 Total Voting Rights and Share Capital
27 Mar 2007 Phase 1/2 Study
21 Mar 2007 Notification of Major Interests in Shares
19 Mar 2007 Notification of Major Interests in Shares
16 Mar 2007 Notification of Major Interests in Shares
12 Mar 2007 Milestone payment from AstraZeneca
28 Feb 2007 Total Voting Rights and Share Capital
27 Feb 2007 Notification of Major Interest in Shares
26 Feb 2007 Notification of Major Interest in Shares
9 Feb 2007 Blocklisting Return
31 Jan 2007 Total Voting Rights and Share Capital
30 Jan 2007 Notification of Major Interest in Shares
24 Jan 2007 Appointment of Non-executive Director
17 Jan 2007 Notification of Major Interest in Shares
11 Jan 2007 Product update
8 Jan 2007 Product submission
8 Jan 2007 Notification of Interest in Shares
8 Jan 2007 Notification of Major Interest in Shares
4 Jan 2007 Company Acquisition
4 Jan 2007 Total Voting Rights and Share Capital
4 Jan 2007 Director Shareholding
3 Jan 2007 Result of Placing and Open Offer
3 Jan 2007 Result of Extraordinary General Meeting
28 Dec 2006 Total Voting Rights and Share Capital
18 Dec 2006 PDMR Shareholding
18 Dec 2006 Director Shareholding
7 Dec 2006 Fundraising, In-Licensing Deals and
Company Acquisition
7 Dec 2006 Interim Results
7 Dec 2006 Appointment of Auditors
4 Dec 2006 Notification of Major Interest in Shares
29 Nov 2006 Notification of Major Interest in Shares
27 Nov 2006 Transfer of Market rights
7 Nov 2006 BLA resubmission
3 Nov 2006 Product Development Programme update
16 Oct 2006 Blocklisting Return
8 Oct 2006 Blocklisting Return
8 Oct 2006 Blocklisting Return
8 Oct 2006 Blocklisting Return
8 Oct 2006 Blocklisting Return
30 Sept 2006 Notification of Major Interest in Shares
27 Sept 2006 Issue of unsecured convertible loan notes
26 Sept 2006 Notification of Major Interests in Shares
22 Sept 2006 Notification of Major Interests in Shares
18 Sept 2006 BLA Submission in the US
5 Sept 2006 Product Data in Leading Journal
8 Aug 2006 Blocklisting Return
19 July 2006 AGM results of Proxy Voting
17 July 2006 Annual Information Update
2. Documents filed at Companies House
Copies of these documents can be obtained from Companies House at Crown Way,
Maindy, Cardiff CF14 3UZ (Telephone +44 (0) 870 3333 636, email at
enquiries@companies-house.gov.uk) or, if you are a registered user, from
Companies House website www.companieshouse.gov.uk
Date Document Filed
25 May 2007 353a - Location of Register of Members
(Non-legible)
24 May 2007 88(2)R - Allotment of Shares
17 May 2007 288a - Director Appointed
16 May 2007 88(2)R - Allotment of Shares
28 Apr 2007 88(2)R - Allotment of Shares
10 Apr 2007 88(2)R - Allotment of Shares
03 Apr 2007 88(2)R - Allotment of Shares
29 Mar 2007 88(2)R - Allotment of Shares
7 Mar 2007 88(2)R - Allotment of Shares
27 Feb 2007 88(2)R - Allotment of Shares
19 Feb 2007 88(2)R - Allotment of Shares
18 Feb 2007 88(2)R - Allotment of Shares
17 Feb 2007 288a - Director Appointed
16 Feb 2007 88(2)R - Allotment of Shares
16 Feb 2007 88(2)R - Allotment of Shares
12 Feb 2007 288c - Director's Particulars Changed
12 Feb 2007 363s - Return made up to 12/01/2007;
Bulk list available separately
20 Jan 2007 Special Resolutions passed at EGM
8 Jan 2007 88(2)R - Allotment of Shares
4 Jan 2007 288c - Director's Particulars Changed
07 Dec 2006 88(2)R - Allotment of Shares
29 Nov 2006 88(2)R - Allotment of Shares
15 Nov 2006 88(2)R - Allotment of Shares
15 Nov 2006 88(2)R - Allotment of Shares
9 Nov 2006 88(2)R - Allotment of Shares
9 Nov 2006 88(2)R - Allotment of Shares
9 Nov 2006 88(2)R - Allotment of Shares
8 Nov 2006 AUD - Auditor's Resignation
16 Aug 2006 88(2)R - Allotment of Shares
9 Aug 2006 88(2)R - Allotment of Shares
27 July 2006 88(2)R - Allotment of Shares
27 July 2006 88(2)R - Allotment of Shares
25 July 2006 Special Resolutions passed at 2006 AGM
18 July 2006 AA - Group of Companies' Accounts made up to
31/03/2006
3. Documents published and sent to shareholders
Date Document Description
27 Jun 2007 Annual Report and financial statements for year
ending 31 March 2007 containing Notice of 2007
Annual General Meeting dated 25 June 2007
8 Dec 2006 Prospectus - Cash Placing and Placing and Open Offer
containing Interim statements and Notice of
Extraordinary General Meeting dated 7 December 2006
Copies of the Company's annual report and financial statements, interim report
together with the Company's Form 20-F are available from the Company's website
at www.protherics.com. Alternatively, the above documents can be obtained
through the Company Secretary at the Company's registered office, the Heath
Business and Technical Park, Runcorn, Cheshire WA7 4QX.
4. Documents filed with the UKLA Document Viewing Facility
Date Document Description
27 Jun 2007 Annual Report and financial statements for year
ending 31 March 2007 containing Notice of AGM
27 Jun 2007 Articles of Association with proposed amendments
27 Jun 2007 Rules of the Protherics PLC 2005 Deferred Bonus
Plan with proposed amendments
4 Jan 2007 Copies of Resolutions passed at Extraordinary
General Meeting held on 3 January 2007
8 Dec 2006 Prospectus - Cash Placing and Placing and Open
Offer containing Interim statements and Notice of
Extraordinary General Meeting to be held
3 January 2007
19 July 2006 Resolutions passed at 2006 Annual General Meeting
Copies of the above documents can be obtained from the United Kingdom Listing
Authority's Document Viewing Facility situated at the Financial Services
Authority, The North Colonnade, Canary Wharf, London E14 5HS.
Ends
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Anna Keeble +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
Protherics PLC announces Annual Information Update
| Source: Protherics PLC
Cheshire, UK--(Marketwire - July 20, 2007) -